Background and objectivesNumerous clinical studies over recent years have reported an inverse relationship between benign prostatic hyperplasia (BPH) size the incidence of prostate cancer (PCa), leading to hypothesis that expanding BPH zone damages glandular tissue where PCa predominately develops. This systematic review aims establish a historical basis reference on zonal origin (PCa) within p...

Hajime Sugiura and Susumu Hasegawa Department of Urology, Nagoya City University Medical School (Director: Prof. N. Oka) Since our original report of transrectal approach using television fluoloscopy for roentgenographic visualization of benign prostatic hyperplasia, we have continued to apply this technique to the cases of benign hyperplasia, carcinoma, inflammatory disease and normal conditio...

Benign prostatic hyperplasia (BPH) often produces chronic and progressive lower urinary tract symptoms or complications as bladder stone, leading many men to seek treatment. Prostatic enlargement due to BPH rarely exceeds 100 g, which occurs in only 4% of men over 70 years of age [1] .Giant BPH is arbitrarily defined as specimens over 200 g[2] or 500 g [3] ;the lower threshold was suggested by ...

A prostate abscess is a rare clinical entity with an incidence of 0.2%-0.5% in males. No case reports exist Staphylococcus haemolyticus as etiologic bacterial agent. We report 59-year-old man past medical history poorly controlled diabetes mellitus and benign prostatic hyperplasia who was hospitalized due to urosepsis obstruction. discovered initially treated intravenous vancomycin ertapenem. C...

Vascular andrology, or angioandrology, was formed on the principle of an interdisciplinary approach in medicine. The object study were pelvic varicose veins, arteriovenous conflicts, chronic pain syndrome, erectile dysfunction, prostatic hyperplasia and lower urinary tract symptoms. New approaches developed within this scientific clinical direction have significantly improved results treatment ...

Human papillomavirus, type 16 (HPV-16) and type 18 (HPV-1 8) are known to play a role in the development of neoplastic disorders of the urogenital organs. The presence of HPV-1 6 and HPV18 in prostatic tissue with benign hyperplasia has been a matter of controversy. Some investigators have reported a high prevalence of HPV-16 DNA and a low prevalence of HPV-18 DNA in prostatic tissue,'-3 while ...

We report a case of symptomatic intraurethral prostatic cyst in a 42-yr-old man without clinical evidence of benign prostatic hyperplasia. The intraurethral cyst makes it unique from the all previously reported cases of prostatic cysts located medially within the prostate. Transurethral resection of the cyst with limited resection of the prostatic tissue at the base of the cyst was performed wi...

Objective: This study is planned to evaluate the histological lesions of prostatic specimens and it’s correlation with the clinical data.Materials and Methods: The present study is a prospective study, undertaken in the Department of Pathology, Mahatma Gandhi Medical College, Jaipur, Rajasthan, during the period of July 2010 to May 2012. This study was conducted on 100 prostatic specimens refer...

Prostatic diseases are a common health problem among males in Western countries, and include chronic prostatic diseases, which have an unclear pathogenesis and few treatment options. In vitro and in vivo studies describe oxidative stress as a major pathway involved in the occurrence of benign prostatic hyperplasia, prostatic cancer and chronic prostatitis. Thus, the oxidative stress cascade is ...

Trichomonas vaginalis causes the most prevalent sexually transmitted infection worldwide. Trichomonads have been detected in prostatic tissues from prostatitis, benign prostatic hyperplasia (BPH), and prostate cancer. Chronic prostatic inflammation is known as a risk factor for prostate enlargement, benign prostatic hyperplasia symptoms, and acute urinary retention. Our aim was to investigate w...